TGFB1 and pulmonary fibrosis: Taken together, our data show that vitamin D treatment inhibited myofibroblast numbers and effectively ameliorated bleomycin-induced pulmonary fibrosis, probably by reducing the basement membrane thickness, preventing organellar injuries, decreasing hydroxyproline accumulation in the lungs and reducing TGF-β expression.